In vitro experiments showed that combining VPS34 inhibitors with the STING agonist ADU-S100 significantly enhanced the release of proinflammatory cytokines in various cancer cell types in a cGAS-STING-dependent manner. This evidence concerns the gene STING1 and cancer.